University of Florida
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Florida sits in the top decile of US sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count).
University of Florida: 1,106 sponsored US clinical trials, 170 recruiting.
University of Florida sponsors 1,106 registered US clinical trials on ClinicalTrials.gov, 170 of them currently recruiting, and 754 completed. 103 of these trials are in Phase 3-4 (later-stage) and 232 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Coronary Artery Disease, with 17 trials.
Top-decile sponsor footprint
University of Florida ranks in the top decile of sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
754 of 855 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,106 total, page 3 of 23
A Mechanistic Study to Investigate tDCS and Working Memory in MCI Patients
NCT05998031
Up-2 Study: Cognitively Engaging Walking Exercise and Neuromodulation to Enhance Brain Function in Older Adults
NCT05830942
Response to Massage in Neck Pain
NCT06224829
All-extremity Exercise During Breast Cancer Chemotherapy
NCT04914663
Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary Intervention
NCT06228456
HIIT Following Breast Cancer Chemotherapy
NCT05913713
Can Immediate Post-injury Fluoxetine Improve the Recovery Trajectories of Victims in Bodily Trauma?
NCT06046859
Rowing Following Breast Cancer Chemotherapy
NCT05848141
Transcranial Pulse Stimulation of the Brain
NCT05910619
Photobiomodulation for Management of Temporomandibular Disorder Pain
NCT05916235
BioFLO for Respiratory Recovery in SCI
NCT06011876
BLOCK-SAH - PPF-Block for Post-SAH Headache
NCT06008795
Exercise to ReGain Stamina and Energy (The EXERGISE Study)
NCT05684367
Frequent Standardized Oral Care Using Human Milk in the Neonatal Intensive Care Unit
NCT06000761
The ROAMM-EHR Study
NCT06263322
Hearts on Fire: Targeting Inflammation in Heart Failure With Preserved Ejection Fraction
NCT07634640
Training Response Artificial Intelligence Network (TRAIN)
NCT05903573
Choosing Wisely: De-implementing Fall Prevention Alarms in Hospitals
NCT06089239
The Potential of Oxytocin to Reduce Opioid Abuse Liability and Pain Among Older Adults
NCT05761860
Use Muscadine Wine Nutraceuticals to Improve Brain Health, Cognition, and Mental Health
NCT05541887
Virtual Physical Therapy Support for Runners
NCT05994833
Comparative Effectiveness of Mobile Health Smoking Cessation Approaches Among Underserved Patients in Primary Care
NCT05415761
Distal Femur Fx: ORIF(Open Reduction and Internal Fixation) vs DFR (Distal Femur Replacement Total Knee Arthroplasty)
NCT05792189
Effects of Breathing and Attention Training (BAT) on Pain Modulation
NCT05773482
Pharmacokinetics and Safety of Epidiferphane and Taxanes in Breast Cancer Patients
NCT05074290
AMPLIFY Study: Transcutaneous Spinal Direct Current Stimulation to Enhance Locomotor Rehabilitation After SCI
NCT05700942
Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI
NCT05681702
Effects of Exercise on Dystonia Pathophysiology
NCT05663840
Pathological Myeloid Activation After Sepsis and Trauma
NCT05616130
Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)
NCT05322850
The Effects of Terrain Variation on Intrinsic Foot Musculature in Healthy Individuals and Individuals With Plantar Fasciitis
NCT05075005
Pre-operative Inspiratory Muscle Strength Training in Total Joint Surgery
NCT05381818
Paired tVNS With ERP in OCD
NCT05580614
Microbiome Dysfunction in Surgical Intensive Care Unit Survivors
NCT05357170
The Less is More Study
NCT05153811
The Path Study: Cognitive and Inflammation Targeted Gut-brain Interventions in Alcohol; Probiotics, Alcohol, Transcutaneous Vagus Nerve Stimulation, and HIV Study
NCT05090267
A Precision Medicine Approach to Identify Patients Undergoing Elective PCI at Risk of Peri-PCI Myocardial Infarction
NCT05332262
Risk Adapted De-Intensification of Radio-Chemotherapy for Oropharyngeal Squamous Cell Carcinoma
NCT05268614
Pain Processing in Inflammatory and Non-Inflammatory Chronic Pain Syndromes
NCT05277025
Telehealth in Lewy Body Dementia
NCT05014971
Dysfunctional Myelopoiesis and Myeloid-Derived Suppressor Cells in Sepsis
NCT05110937
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
NCT05000294
Effect of Beet Juice Supplementation on Vascular and Inspiratory Muscle Function
NCT04920799
Opioid-Sparing and Pain-Reducing Properties of Syntocinon: A Dose-Effect Determination
NCT04218409
Pervasive Sensing and AI in Intelligent ICU
NCT05127265
A Stress and Pain Self-management m-Health App for Adult Outpatients With Sickle Cell Disease
NCT04484272
ANCHORS Alcohol & Sexual Health Study: UH3 Project
NCT04331704
Low-Dose Pioglitazone in Patients With NASH (AIM 2)
NCT04501406
Planned Semi-Elective Lung Tx Study
NCT04601818
Mechanisms and Modulation of Pain Modulatory Capacity
NCT04441619
What is open in the University of Florida pipeline
170 recruiting of 1,106 indexed (15% open); 754 completed (68%).
Phase mix: 103 late (III/IV) vs 232 early (I/II) (early-phase heavy).
Top condition: Coronary Artery Disease (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Florida: open-pipeline peers nationwide
Peers matched on 1,106 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Florida sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,106 trials (± recruiting share)
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Arrowhead Regional Medical Center · 15% recruiting · 13 trials
- Aurinia Pharmaceuticals · 15% recruiting · 13 trials
- Bronx VA Medical Center · 15% recruiting · 13 trials
- Candel Therapeutics · 15% recruiting · 13 trials
Related
What to do with this University of Florida page
1,106 registered trials is a research-attention snapshot, not an endorsement of University of Florida or any single study.
- 170 of University of Florida's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Coronary Artery Disease is the condition University of Florida studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Coronary Artery Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Florida pipeline card: 1,106 registered trials from official public datasets.Report a data error.